COVID19 Prevalence and Antibody Seroprevalence  Among Individuals with Intellectual Disability

Scott  Spreat; Tiffany Adams; Darlene Barnes; Jennifer Caputo; Dawn  Diamond; Tine Hansen-Turton; Deborah Jones; Stephen Kolesk

COVID19 Prevalence and Antibody Seroprevalence Among Individuals with Intellectual Disability

Authors

Scott Spreat
Tiffany Adams Woods Services
Darlene Barnes Woods Services
Jennifer Caputo Woods Services
Dawn Diamond Woods Services
Tine Woods Services
Deborah Jones Woods Services
Stephen Kolesk Woods Services

Keywords:

covid-19; antibodies;

Abstract

Approximately 20% of the residential census at a population healthcare facility tested positive for COVID19 during the period from March 2020 through early June 2020. Individuals residing within the facility had intellectual disability, autism, and/or brain injury. Fifteen were hospitalized, but all subsequently were discharged. Two hospitalized clients died as a result of factors unrelated to COVID-19, aned a third was pronounced dead upon arrival at the Emergency room, again as a result of factors unrelated to COVID-19. individuals died as a result of factors unrelated to COVID-19. Approximately ¾ of the infected clients developed antibodies within 28 days of initial diagnosis. The development of antibodies could not be predicted from readily available demographic or medical variables

Downloads

Published

2020-09-18

How to Cite

Spreat, S. ., Adams, T., Barnes, D., Caputo, J., Diamond, D. ., Hansen-Turton, T., … Kolesk, S. (2020). COVID19 Prevalence and Antibody Seroprevalence Among Individuals with Intellectual Disability . Social Innovations Journal, 3. Retrieved from https://socialinnovationsjournal.com/index.php/sij/article/view/538

Download Citation

Issue

Vol. 3 (2020): Social Accountability and Accreditation; Interprofessional Education and Team Based Care; and Population Health Approaches to Global Health Access and Equitable Health

Section

Equity and Justice

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The Social Innovations Journal permits the Creative Commons License:

CC Attribution-NonCommercial-NoDerivatives 4.0

Under the following terms:

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material

Copyright and Publishing Rights

For the licenses indicated above, authors retain the copyright and full publishing rights without restrictions.